Total Funding
32
42
Total FundingSeed raised
Growth Score 32 in past quarter
-5 pts
Heat Score 42 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
82331
AC BioScience is a biotech company that develops personalized molecular therapies designed for cancer patients.
- Andreas Schlaepfer: CEO & Chairman
About the Company
AC BioScience is a start-up biotech company with an innovative vision and business model. We are dedicated to developing new therapies to fight a range of cancers. Founded by Andreas Schläpfer and Professor Christian Auclair, an internationally recognized expert in molecular oncology, the company is leading a paradigm shift in cancer therapeutics.
The company is headquartered at the EPFL Innovation Park near Lausanne, and celebrated its first year of existence in March 2018.